Rajiv Nayar
Rajiv Nayar publishes mostly in Molecular Biology, Oncology and Biomaterials, on topics such as Lipid Membrane Structure and Behavior, Nanoparticle-Based Drug Delivery and Protein purification and stability.
- World rank
- #1,428,246 of 7,710,434 ranked researchers
- Rank in United States
- #450,145 of 1,627,098
- Works
- 55
- Citations
- 2k
- Citations per work
- 36.1
What does Rajiv Nayar research?
Rajiv Nayar's work is mostly in Biochemistry, Genetics and Molecular Biology (38%), Medicine (18%), Materials Science (6%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else2138.0%
- Life Sciences2137.9%
- Health Sciences1017.9%
- Medicine1017.9%
- Physical Sciences36.2%
- Materials Science36.2%
- 1Molecular Biology33% of their works
- 2Oncology8% of their works
- 3Biomaterials6% of their works
- 4Cancer Research5% of their works
- 5Radiology, Nuclear Medicine and Imaging5% of their works
- 6Pulmonary and Respiratory Medicine5% of their works
Research topics
- Lipid Membrane Structure and Behavior
- Nanoparticle-Based Drug Delivery
- Protein purification and stability
- Monoclonal and Polyclonal Antibodies Research
- RNA Interference and Gene Delivery
- Mitochondrial Function and Pathology
- Botulinum Toxin and Related Neurological Disorders
- Cancer Treatment and Pharmacology
Which keywords describe Rajiv Nayar's research?
The keywords of their largest research topics: Lipid Rafts, Membrane Lipids, Monoclonal Antibodies, Therapeutic Antibodies, Drug Delivery, Nanocarriers, Biopharmaceuticals and Protein Aggregation.
- Taxanes
- Neurotoxins
- Chemotherapy-Induced Peripheral Neuropathy
- siRNA Delivery
- Fc Receptors
- Protein Aggregation
- Nanocarriers
- Therapeutic Antibodies
- Membrane Lipids
- Lipid Rafts
- Monoclonal Antibodies
- Drug Delivery
- Biopharmaceuticals
- Antibody Engineering
- RNA Interference
- Botulinum Toxin
- Mitochondria
- Reactive Oxygen Species
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 18 words, with their numbers
- Lipid Rafts171 topic
- Membrane Lipids171 topic
- Monoclonal Antibodies152 topics
- Therapeutic Antibodies152 topics
- Drug Delivery91 topic
- Nanocarriers91 topic
- Biopharmaceuticals81 topic
- Protein Aggregation81 topic
- Antibody Engineering71 topic
- Fc Receptors71 topic
- RNA Interference61 topic
- siRNA Delivery61 topic
- Botulinum Toxin41 topic
- Chemotherapy-Induced Peripheral Neuropathy41 topic
- Mitochondria41 topic
- Neurotoxins41 topic
- Reactive Oxygen Species41 topic
- Taxanes41 topic
Where does Rajiv Nayar work?
Rajiv Nayar's main affiliation in the publication record is HTD Biosystems (United States), United States.
How many publications and citations does Rajiv Nayar have?
OpenAlex counts 55 works and 1,984 citations for Rajiv Nayar, an h-index of 25, ranking #1,428,246 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Rajiv Nayar. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.